Women ages40+ shouldhave a clinicalbreast examat least yearlyLCISPalbociclibMetastasisCDK4/6InhibitorsOligometastasesIntraductalPapillomaCAMMorpheaFlowCytometryLymphoscintigraphyChemopreventionSelf-examinationmTORInhibitorsLumpHormoneReceptorStatusTyrosine-KinaseInhibitorER+/-GeneticCounselingECOGScoreAdenocarcinomaGailModelMethotrexateEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearChemotherapyBreastTomosynthesisMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be felt5-FluorouracilBI-RADSCystCytostaticAyurvedaBreastCancerIn-situCarcinomaBiopsyPhysicalactivity mayreduce therisk of breastcancersPrecisionMedicineKi-67RateRADLumpectomyAdvocacyTamoxifenPagetDiseaseAromataseInhibitorsPathologicResponseMultifocalTumorsAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenEGFRHormoneReplacementTherapyDefinitiveSurgeryTriple +/-BreastCancerBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55PARPInhibitorsLapatinibBrachytherapyMegestrolAcetateKappaEpsilonLymphNodeStatusFamilyHistoryAdjuvantTherapyDocetaxelOvarianSuppressionCyclophosphamideBevacizumabMastectomyNeoadjuvantTherapyPalpationSERMAlopeciaDown-StagingRelapseTumorGradeRadiotherapyDoseDenseTherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.CalcificationsBRCAGeneBOCAMRIWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.BilateralProphylacticMastectomyCytotoxicProgestinDoxorubicinCapecitabineFISHAngiogenesisApoptosisPI3KinaseInhibitorsHerceptinMastodyniaGeneticPredispositionStagingGeneMutationGuaranteedRenewableInsuranceCo-survivorFibroadenomaDimplingCachexiaGermlineMutationPhyllodesTumorImmunotherapyCheckpointInhibitorAntiemeticsMultimodalityTherapyAntibodyTherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerPaclitaxelACChemotherapyHER-2AnastrozoleEstrogen/EstradiolAbsoluteRisk1 in 8womenRaloxifeneCMFChemotherapyWomen ages40+ shouldhave a clinicalbreast examat least yearlyLCISPalbociclibMetastasisCDK4/6InhibitorsOligometastasesIntraductalPapillomaCAMMorpheaFlowCytometryLymphoscintigraphyChemopreventionSelf-examinationmTORInhibitorsLumpHormoneReceptorStatusTyrosine-KinaseInhibitorER+/-GeneticCounselingECOGScoreAdenocarcinomaGailModelMethotrexateEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearChemotherapyBreastTomosynthesisMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be felt5-FluorouracilBI-RADSCystCytostaticAyurvedaBreastCancerIn-situCarcinomaBiopsyPhysicalactivity mayreduce therisk of breastcancersPrecisionMedicineKi-67RateRADLumpectomyAdvocacyTamoxifenPagetDiseaseAromataseInhibitorsPathologicResponseMultifocalTumorsAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenEGFRHormoneReplacementTherapyDefinitiveSurgeryTriple +/-BreastCancerBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55PARPInhibitorsLapatinibBrachytherapyMegestrolAcetateKappaEpsilonLymphNodeStatusFamilyHistoryAdjuvantTherapyDocetaxelOvarianSuppressionCyclophosphamideBevacizumabMastectomyNeoadjuvantTherapyPalpationSERMAlopeciaDown-StagingRelapseTumorGradeRadiotherapyDoseDenseTherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.CalcificationsBRCAGeneBOCAMRIWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.BilateralProphylacticMastectomyCytotoxicProgestinDoxorubicinCapecitabineFISHAngiogenesisApoptosisPI3KinaseInhibitorsHerceptinMastodyniaGeneticPredispositionStagingGeneMutationGuaranteedRenewableInsuranceCo-survivorFibroadenomaDimplingCachexiaGermlineMutationPhyllodesTumorImmunotherapyCheckpointInhibitorAntiemeticsMultimodalityTherapyAntibodyTherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerPaclitaxelACChemotherapyHER-2AnastrozoleEstrogen/EstradiolAbsoluteRisk1 in 8womenRaloxifeneCMFChemotherapy

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
  1. Women ages 40+ should have a clinical breast exam at least yearly
  2. LCIS
  3. Palbociclib
  4. Metastasis
  5. CDK4/6 Inhibitors
  6. Oligometastases
  7. Intraductal Papilloma
  8. CAM
  9. Morphea
  10. Flow Cytometry
  11. Lymphoscintigraphy
  12. Chemoprevention
  13. Self-examination
  14. mTOR Inhibitors
  15. Lump
  16. Hormone Receptor Status
  17. Tyrosine-Kinase Inhibitor
  18. ER +/-
  19. Genetic Counseling
  20. ECOG Score
  21. Adenocarcinoma
  22. Gail Model
  23. Methotrexate
  24. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  25. Chemotherapy
  26. Breast Tomosynthesis
  27. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  28. 5-Fluorouracil
  29. BI-RADS
  30. Cyst
  31. Cytostatic
  32. Ayurveda
  33. Breast Cancer
  34. In-situ Carcinoma
  35. Biopsy
  36. Physical activity may reduce the risk of breast cancers
  37. Precision Medicine
  38. Ki-67 Rate
  39. RAD
  40. Lumpectomy
  41. Advocacy
  42. Tamoxifen
  43. Paget Disease
  44. Aromatase Inhibitors
  45. Pathologic Response
  46. Multifocal Tumors
  47. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  48. EGFR
  49. Hormone Replacement Therapy
  50. Definitive Surgery
  51. Triple +/- Breast Cancer
  52. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  53. PARP Inhibitors
  54. Lapatinib
  55. Brachytherapy
  56. Megestrol Acetate
  57. Kappa Epsilon
  58. Lymph Node Status
  59. Family History
  60. Adjuvant Therapy
  61. Docetaxel
  62. Ovarian Suppression
  63. Cyclophosphamide
  64. Bevacizumab
  65. Mastectomy
  66. Neoadjuvant Therapy
  67. Palpation
  68. SERM
  69. Alopecia
  70. Down-Staging
  71. Relapse
  72. Tumor Grade
  73. Radiotherapy
  74. Dose Dense Therapy
  75. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  76. Calcifications
  77. BRCA Gene
  78. BOCA
  79. MRI
  80. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  81. Bilateral Prophylactic Mastectomy
  82. Cytotoxic
  83. Progestin
  84. Doxorubicin
  85. Capecitabine
  86. FISH
  87. Angiogenesis
  88. Apoptosis
  89. PI3 Kinase Inhibitors
  90. Herceptin
  91. Mastodynia
  92. Genetic Predisposition
  93. Staging
  94. Gene Mutation
  95. Guaranteed Renewable Insurance
  96. Co-survivor
  97. Fibroadenoma
  98. Dimpling
  99. Cachexia
  100. Germline Mutation
  101. Phyllodes Tumor
  102. Immunotherapy
  103. Checkpoint Inhibitor
  104. Antiemetics
  105. Multimodality Therapy
  106. Antibody Therapy
  107. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  108. Paclitaxel
  109. AC Chemotherapy
  110. HER-2
  111. Anastrozole
  112. Estrogen/Estradiol
  113. Absolute Risk
  114. 1 in 8 women
  115. Raloxifene
  116. CMF Chemotherapy